<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Rx Times Pharmacy Magazine&#187; BioCryst</title>
	<atom:link href="http://www.rxtimes.com/tag/biocryst/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.rxtimes.com</link>
	<description>Pharmacy news, jobs, continuing education, community and more.</description>
	<lastBuildDate>Mon, 09 Jan 2012 03:45:59 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>FDA Authorizes Peramivir for H1N1</title>
		<link>http://www.rxtimes.com/fda-authorizes-peramivir-for-h1n1/</link>
		<comments>http://www.rxtimes.com/fda-authorizes-peramivir-for-h1n1/#comments</comments>
		<pubDate>Sat, 24 Oct 2009 01:41:12 +0000</pubDate>
		<dc:creator>Rick Jackson</dc:creator>
				<category><![CDATA[Pharmacy]]></category>
		<category><![CDATA[BioCryst]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Flu]]></category>
		<category><![CDATA[H1N1]]></category>
		<category><![CDATA[Peramivir]]></category>

		<guid isPermaLink="false">http://www.rxtimes.com/?p=4177</guid>
		<description><![CDATA[Washington, DC &#8211; In response to a request from the U.S. Centers for Disease Control and Prevention, The Food and Drug Administration has issued an emergency use authorization for the intravenous (IV) investigational antiviral drug Peramivir, to be used in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are [...]]]></description>
		<wfw:commentRss>http://www.rxtimes.com/fda-authorizes-peramivir-for-h1n1/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

